Research progress on the mechanism of PD-1/PD-L1 axis regulation of non-small cell lung cancer and its intervention with Chinese herbal medicine

View at publisher Summarise with VIRAT
Authors: Jindi Ma, Yuhui HAN, Xiaoling GAO
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

非小细胞肺癌(NSCLC)是严重威胁人类健康的高发病率恶性肿瘤,其防治面临肿瘤耐药性、药物毒副作用及转移复发等多重挑战。中医药作为确有疗效的补充治疗手段,其在NSCLC治疗中的应用价值已获得广泛认可。NSCLC的发生发展机制复杂,其中PD-1/PD-L1免疫检查点通路在肿瘤免疫逃逸中发挥关键调控作用。近年来,多项研究聚焦于中药及其活性成分通过靶向调控PD-1/PD-L1信号轴增强抗肿瘤免疫应答。系统梳理该领域研究进展,有助于揭示NSCLC免疫调控的新靶点,也将为NSCLC的中药免疫治疗策略提供思路与依据。

Fields of Study & Subjects

Cancer Immunotherapy and Biomarkers Ferroptosis and cancer prognosis Traditional Chinese Medicine Clinical Research

Publication details

Journal / source
Lishizhen Medicine and Materia Medica Research
Volume
37
Issue
5
Pages
937–944
Publication date
1 March 2026
Language
EN